SCNI Scinai Immunotherapeutics Ltd.

NASDAQ
$1.55

Scinai Immunotherapeutics Ltd. (SCNI) is expected to report earnings on November 23, 2026, before the market open.

Scinai Immunotherapeutics Reported Earnings
Monday, August 24, 2026 · 7:00 AM ET
Earnings Date
Nov 23
Monday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is based in JERUSALEM.

Industry

Medical Practitioners

Charts powered in part by Lightweight Charts™ by TradingView.